Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease

Aging

Volumn 3, Issue 9, 2011, Pages 846-851

  Song, Bing ^a   Davis, Korbin ^b   Liu, X Shawn ^b   Lee, Hyoung gon ^d   Smith, Mark ^d   Liu, Xiaoqi ^b,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Purdue University   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cell cycle; phosphorylation; Plk1; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CELL CYCLE PROTEIN; DYNACTIN; MICROTUBULE ASSOCIATED PROTEIN; NERVE GROWTH FACTOR; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CELL CYCLE; CELL DEATH; CELL STRAIN; DNA REPLICATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; DNA REPLICATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RATS;

EID: 84862833670     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100382     Document Type: Article

References (28)

1. Zekanowski C, Wojda U. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease. Acta Neurobiol Exp (Wars). 2009;69:232-53.
2. Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci. 2006;26:775-84.
3. Evans TA, Raina AK, Delacourte A, Aprelikova O, Lee HG, Zhu X, et al. BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci. 2007;4:140-5.
4. Currais A, Hortobagyi T, Soriano S. The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging. 2009;1:363-71.
5. Bonda DJ, Evans TA, Santocanale C, Llosa JC, Vina J, Bajic VP, et al. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging. 2009;1:382-8.
6. Lee HG, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, et al. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int. 2009;54:84-8.
7. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem. 1995;58:160-74.
8. Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov. 2010;9:643-60.
9. Winkles JA, Alberts GF. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene. 2005;24:260-6.
10. Yim H, Erikson RL. Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation. Mol Cell Biol. 2009;29:2609-21.
11. Wu ZQ, Liu X. Role for Plk1 phosphorylation of Hbo1 in regulation of replication licensing. Proc Natl Acad Sci U S A. 2008;105:1919-24.
12. Trenz K, Errico A, Costanzo V. Plx1 is required for chromosomal DNA replication under stressful conditions. EMBO J. 2008;27:876-85.
13. Harris PL, Zhu X, Pamies C, Rottkamp CA, Ghanbari HA, McShea A, et al. Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiol Aging. 2000;21:837-41.
14. Li H, Liu XS, Yang X, Song B, Wang Y, Liu X. Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase. Proc Natl Acad Sci U S A. 2010;107:14633-8.
15. Eschbach J, Dupuis L. Cytoplasmic dynein in neurodegeneration. Pharmacol Ther. 2011;130:348-63.
16. Sanchez-Martin FJ, Valera E, Casimiro I, Merino JM. Nerve growth factor increases the sensitivity to zinc toxicity and induces cell cycle arrest in PC12 cells. Brain Res Bull. 2010;81:458-66.
17. Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, Krssak M, et al. BI 2536, a potent and selective inhibitor of pololike kinase 1, inhibits tumor growth in vivo. Curr Biol. 2007;17:316-22.
18. Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta. 2007;1772:494-502.
19. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol. 1997;150:1933-9.
20. Vincent I, Jicha G, Rosado M, Dickson DW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci. 1997;17:3588-98.
21. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, et al. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol. 2003;105:524-8.
22. Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging. 2009;1:281-8.
23. Renner AG, Creancier L, Dos Santos C, Fialin C, Recher C, Bailly C, et al. A functional link between polo-like kinase 1 and the mammalian target-of-rapamycin pathway? Cell Cycle. 2010;9:1690-6.
24. Matthew EM, Hart LS, Astrinidis A, Navaraj A, Dolloff NG, Dicker DT, et al. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions. Cell Cycle. 2009;8:4168-75.
25. Xu J, Chen S, Ku G, Ahmed SH, Chen H, Hsu CY. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab. 2001;21:702-10.
26. Liu X, Lei M, Erikson RL. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol Cell Biol. 2006;26:2093-108.
27. Li H, Liu XS, Yang X, Song B, Wang Y, Liu X. Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:14633-8.
28. Stuermer A, Hoehn K, Faul T, Auth T, Brand N, Kneissl M, et al. Mouse pre-replicative complex proteins colocalise and interact with the centrosome. Eur J Cell Biol. 2007;86:37-50.